| All tumors (N = 188) | VHL mutated tumors (N = 115) | Wildtype tumors (N = 73) |  |  | |||
---|---|---|---|---|---|---|---|---|
 | N | % | N | % | N | % | χ2 | p-value †|
T (TNM*) | Â | Â | Â | Â | Â | Â | Â | Â |
1 | 5 | 2.7 | 4 | 3.5 | 1 | 1.4 | Â | Â |
2 | 93 | 49.5 | 55 | 47.8 | 38 | 52.1 | Â | Â |
3A | 35 | 18.6 | 20 | 17.4 | 15 | 20.6 | Â | Â |
3B | 50 | 26.6 | 34 | 29.6 | 16 | 21.9 | Â | Â |
4 | 2 | 1.1 | 1 | 0.9 | 1 | 1.4 | 0.18§** | 0.67 |
X | 3 | 1.6 | 1 | 0.9 | 2 | 2.7 | Â | Â |
N (TNM*) | Â | Â | Â | Â | Â | Â | Â | Â |
0 | 126 | 67.0 | 78 | 67.8 | 48 | 65.8 | Â | Â |
1 | 7 | 3.7 | 6 | 5.2 | 1 | 1.4 | Â | Â |
2 | 7 | 3.7 | 5 | 4.4 | 2 | 2.7 | 1.51¶** | 0.22 |
X | 48 | 25.5 | 26 | 22.6 | 22 | 30.1 | Â | Â |
M (TNM*) | Â | Â | Â | Â | Â | Â | Â | Â |
0 | 131 | 69.7 | 77 | 67.0 | 54 | 74.0 | Â | Â |
1 | 26 | 13.8 | 18 | 15.7 | 8 | 11.0 | 0.99** | 0.32 |
X | 31 | 16.5 | 20 | 17.4 | 11 | 15.1 | Â | Â |
Stage (TNM*) | Â | Â | Â | Â | Â | Â | Â | Â |
1 | 5 | 2.7 | 4 | 3.5 | 1 | 1.4 | Â | Â |
2 | 83 | 44.2 | 46 | 40.0 | 37 | 50.7 | Â | Â |
3 | 66 | 35.1 | 42 | 36.5 | 24 | 32.9 | Â | Â |
4 | 32 | 17.0 | 22 | 19.1 | 10 | 13.7 | 1.41§** | 0.24 |
X | 2 | 1.1 | 1 | 0.9 | 1 | 1.4 | Â | Â |
Nuclear grading †‡ |  |  |  |  |  |  |  |  |
I | 46 | 24.5 | 27 | 23.5 | 19 | 26.0 | Â | Â |
II | 67 | 35.6 | 43 | 37.4 | 24 | 32.9 | Â | Â |
III | 48 | 25.5 | 29 | 25.2 | 19 | 26.0 | Â | Â |
IV | 27 | 14.4 | 16 | 13.9 | 11 | 15.1 | 0.43 | 0.94 |